SSEAMCYTE Trademark Information

Life Science Institute, Inc.

Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; ph...

Perfect for these industries

Words that describe this mark

cells   medical   use   stem   cells   medical   purposes   pharmaceutical   preparations   containing   cells   treatment   epidermolysis   bullosa     cerebral   infarction     stroke   apoplexia   cerebri     acute   myocardial   infarction   spinal  

This is a brand page for the SSEAMCYTE trademark by Life Science Institute, Inc.  in Tokyo, , 100-8251.

Write a review about a product or service associated with this SSEAMCYTE trademark. Or, contact the owner Life Science Institute, Inc. of the SSEAMCYTE trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the SSEAMCYTE trademark.

On Friday, January 4, 2019, a U.S. federal trademark registration was filed for SSEAMCYTE. The USPTO has given the SSEAMCYTE trademark serial number of 88250267. The current federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED. The correspondent listed for SSEAMCYTE is DANIELLE I. MATTESSICH of MERCHANT & GOULD P.C., P.O. BOX 2910, MINNEAPOLIS, MN, 55402-0910 . The SSEAMCYTE trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for SSEAMCYTE is Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries.

Word mark: SSEAMCYTE
Status/Status Date:
NOTICE OF ALLOWANCE - ISSUED
6/16/2020
Serial Number: 88250267
Filing Date: 1/4/2019
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/21/2020
Last Applicant/Owner: Life Science Institute, Inc.
Tokyo 100-8251
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
MERCHANT & GOULD P.C.
P.O. BOX 2910
MINNEAPOLIS, MN, 55402-0910

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your SSEAMCYTE trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $199/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
6/16/2020
NOTICE OF ALLOWANCE - ISSUED
Correspondent Search:

DANIELLE I. MATTESSICH is a correspondent of SSEAMCYTE trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: